FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163233971> ?p ?o ?g. }

• W2163233971 endingPage "277" @default.
• W2163233971 startingPage "268" @default.
• W2163233971 abstract "Since there are very few affordable antileishmanial drugs available, antimonial resistance has crippled antileishmanial therapy, thereby emphasising the need for development of novel therapeutic strategies. This study aimed to evaluate the antileishmanial role of combined therapy with sodium antimony gluconate (SAG) and the triterpenoid glycyrrhizic acid (GA) against infection with SAG-resistant Leishmania (GE1F8R). Combination therapy with GA and SAG successfully limited infection with SAG-resistant Leishmania in a synergistic manner (fractional inhibitory concentration index <1.0). At the same time, mice infected with SAG-resistant Leishmania and co-treated with GA and SAG exhibited a significant reduction in hepatic and splenic parasite burden. In probing the mechanism, it was observed that GA treatment suppressed the expression and efflux activity of P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1), two host ABC transporters responsible for antimony efflux from host cells infected with SAG-resistant parasites. This suppression correlated with greater intracellular antimony retention during SAG therapy both in vitro and in vivo, which was reflected in the reduced parasite load. Furthermore, co-administration of GA and SAG induced a shift in the cytokine balance towards a Th1 phenotype by augmenting pro-inflammatory cytokines (such as IL-12, IFNγ and TNFα) and inducing nitric oxide generation in GE1F8R-infected macrophages as well as GE1F8R-infected mice. This study aims to provide an affordable leishmanicidal alternative to expensive antileishmanial drugs such as miltefosine and amphotericin B. Furthermore, this report explores the role of GA as a resistance modulator in MRP1- and P-gp-overexpressing conditions." @default.
• W2163233971 created "2016-06-24" @default.
• W2163233971 creator A5006550633 @default.
• W2163233971 creator A5007896564 @default.
• W2163233971 creator A5028366364 @default.
• W2163233971 creator A5075835459 @default.
• W2163233971 creator A5083535637 @default.
• W2163233971 creator A5086378853 @default.
• W2163233971 date "2015-03-01" @default.
• W2163233971 modified "2023-09-23" @default.
• W2163233971 title "Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis" @default.
• W2163233971 cites W1539233028 @default.
• W2163233971 cites W1741332071 @default.
• W2163233971 cites W1964666902 @default.
• W2163233971 cites W1978577434 @default.
• W2163233971 cites W1984979458 @default.
• W2163233971 cites W1992665196 @default.
• W2163233971 cites W1993839026 @default.
• W2163233971 cites W1996871835 @default.
• W2163233971 cites W1998855247 @default.
• W2163233971 cites W1999277384 @default.
• W2163233971 cites W2006318766 @default.
• W2163233971 cites W2016562927 @default.
• W2163233971 cites W2029976352 @default.
• W2163233971 cites W2034144554 @default.
• W2163233971 cites W2046494390 @default.
• W2163233971 cites W2065800378 @default.
• W2163233971 cites W2079515614 @default.
• W2163233971 cites W2082293404 @default.
• W2163233971 cites W2084070944 @default.
• W2163233971 cites W2111218068 @default.
• W2163233971 cites W2125483721 @default.
• W2163233971 cites W2126420606 @default.
• W2163233971 cites W2129087217 @default.
• W2163233971 cites W2139456667 @default.
• W2163233971 cites W2147175809 @default.
• W2163233971 cites W2163781429 @default.
• W2163233971 cites W2166510876 @default.
• W2163233971 cites W2170956456 @default.
• W2163233971 doi "https://doi.org/10.1016/j.ijantimicag.2014.10.023" @default.
• W2163233971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25600891" @default.
• W2163233971 hasPublicationYear "2015" @default.
• W2163233971 type Work @default.
• W2163233971 sameAs 2163233971 @default.
• W2163233971 citedByCount "28" @default.
• W2163233971 countsByYear W21632339712015 @default.
• W2163233971 countsByYear W21632339712016 @default.
• W2163233971 countsByYear W21632339712017 @default.
• W2163233971 countsByYear W21632339712018 @default.
• W2163233971 countsByYear W21632339712019 @default.
• W2163233971 countsByYear W21632339712020 @default.
• W2163233971 countsByYear W21632339712021 @default.
• W2163233971 countsByYear W21632339712022 @default.
• W2163233971 crossrefType "journal-article" @default.
• W2163233971 hasAuthorship W2163233971A5006550633 @default.
• W2163233971 hasAuthorship W2163233971A5007896564 @default.
• W2163233971 hasAuthorship W2163233971A5028366364 @default.
• W2163233971 hasAuthorship W2163233971A5075835459 @default.
• W2163233971 hasAuthorship W2163233971A5083535637 @default.
• W2163233971 hasAuthorship W2163233971A5086378853 @default.
• W2163233971 hasConcept C136764020 @default.
• W2163233971 hasConcept C150903083 @default.
• W2163233971 hasConcept C185592680 @default.
• W2163233971 hasConcept C200082930 @default.
• W2163233971 hasConcept C203014093 @default.
• W2163233971 hasConcept C207001950 @default.
• W2163233971 hasConcept C2776555147 @default.
• W2163233971 hasConcept C2778689377 @default.
• W2163233971 hasConcept C2780122544 @default.
• W2163233971 hasConcept C2781092759 @default.
• W2163233971 hasConcept C2781333301 @default.
• W2163233971 hasConcept C2781417161 @default.
• W2163233971 hasConcept C41008148 @default.
• W2163233971 hasConcept C55493867 @default.
• W2163233971 hasConcept C71924100 @default.
• W2163233971 hasConcept C71928629 @default.
• W2163233971 hasConcept C86803240 @default.
• W2163233971 hasConcept C89423630 @default.
• W2163233971 hasConcept C98274493 @default.
• W2163233971 hasConceptScore W2163233971C136764020 @default.
• W2163233971 hasConceptScore W2163233971C150903083 @default.
• W2163233971 hasConceptScore W2163233971C185592680 @default.
• W2163233971 hasConceptScore W2163233971C200082930 @default.
• W2163233971 hasConceptScore W2163233971C203014093 @default.
• W2163233971 hasConceptScore W2163233971C207001950 @default.
• W2163233971 hasConceptScore W2163233971C2776555147 @default.
• W2163233971 hasConceptScore W2163233971C2778689377 @default.
• W2163233971 hasConceptScore W2163233971C2780122544 @default.
• W2163233971 hasConceptScore W2163233971C2781092759 @default.
• W2163233971 hasConceptScore W2163233971C2781333301 @default.
• W2163233971 hasConceptScore W2163233971C2781417161 @default.
• W2163233971 hasConceptScore W2163233971C41008148 @default.
• W2163233971 hasConceptScore W2163233971C55493867 @default.
• W2163233971 hasConceptScore W2163233971C71924100 @default.
• W2163233971 hasConceptScore W2163233971C71928629 @default.
• W2163233971 hasConceptScore W2163233971C86803240 @default.
• W2163233971 hasConceptScore W2163233971C89423630 @default.
• W2163233971 hasConceptScore W2163233971C98274493 @default.

• next